Day One Biopharmaceuticals, Inc. (DAWN) Balance Sheet Quarterly - Discounting Cash Flows
DAWN
Day One Biopharmaceuticals, Inc.
DAWN (NASDAQ)
Period Ending: 2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
Report Filing: 2025-11-04 2025-08-05 2025-05-06 2025-02-25 2024-10-30 2024-08-02
1234
Total Current Assets 490 494.4 508.7 562.3 581 383.2
1234
Cash and Short Term Investments 451.6 453.1 473 531.7 558.4 361.9
1234
Cash & Equivalents 43.28 35.62 33.36 125 422.8 239.6
1234
Short Term Investments 408.3 417.5 439.7 406.8 135.6 122.2
1234
Receivables 16.7 19.67 18.05 13.88 8.7 9.14
1234
Inventory 7.06 6.54 3.56 3.32 2.73 0.151
1234
Other Current Assets 14.63 15.11 14.01 13.41 11.18 12.01
1234
Total Assets 513.8 519 534.4 582.8 600.8 400.4
1234
Total Non-Current Assets 23.81 24.61 25.7 20.46 19.81 17.28
1234
Property, Plant and Equipment 4.68 4.82 5.08 4.71 3.48 0.36
1234
Goodwill and Intangible Assets 18.82 19.61 20.41 15.63 16.22 16.8
1234
Goodwill 0 0 0 0 0 0
1234
Intangible Assets 18.82 19.61 20.41 15.63 16.22 16.8
1234
Long Term Investments 0 0 0 0 0 0
1234
Deferred Tax Assets 0 0 0 0 0 0
1234
Other Long Term Assets 0.317 0.183 0.215 0.121 0.117 0.117
1234
Total Current Liabilities 56.47 51.22 47.88 73.45 39.74 93.71
1234
Accounts Payable 5.78 5.09 2.54 3.26 3.02 6.44
1234
Notes Payable/Short Term Debt 0.161 0.153 0.062 0.01 0.077 0.19
1234
Tax Payables 0 0 4.97 0 0 0
1234
Deferred Revenue 2.32 1.85 1.64 1.55 1.46 0
1234
Other Current Liabilities 48.21 44.13 38.67 68.62 35.19 87.07
1234
Total Liabilities 62.91 58.2 54.84 80.04 45.34 93.71
1234
Total Non-Current Liabilities 6.45 6.98 6.96 6.59 5.6 0
1234
Total Long Term Debt 2.73 2.85 2.85 2.59 2.54 0
1234
Deferred Tax Liabilities Non-Current 0 0 0 0 0 0
1234
Deferred Revenue Non-Current 2.95 3.37 3.35 3.23 3.06 0
1234
Capital Lease Obligations 2.73 2.85 2.85 2.59 2.54 0
1234
Other Long Term Liabilities -1.97 -2.09 -2.09 -1.83 -2.54 0
1234
Total Equity 450.9 460.8 479.5 502.8 555.5 306.7
1234
Non-Controlling Interest 0 0 0 0 0 0
1234
Total Stockholders' Equity 450.9 460.8 479.5 502.8 555.5 306.7
1234
Retained Earnings -640.1 -620.4 -590.1 -554.1 -488.4 -525.4
1234
Accumulated Other Earnings 0.069 -0.092 -0.052 0.084 -0.006 -0.022
1234
Common Stock 0.01 0.01 0.01 0.01 0.01 0.009
1234
Preferred Stock 0 0 0 0 0 0
1234
Additional Paid in Capital 1,091 1,081 1,070 1,057 1,044 832.1
1234
Total Liabilities & Total Equity 513.8 519 534.4 582.8 600.8 400.4
1234
Total Liabilities & Shareholders' Equity 513.8 519 534.4 582.8 600.8 400.4
1234
Total Investments 408.3 417.5 439.7 406.8 135.6 122.2
1234
Total Debt 2.89 3 2.92 2.6 2.62 0.19
1234
Net Debt -40.38 -32.62 -30.44 -122.4 -420.1 -239.4
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program